Project Dyszombie – Lab Notes

The following is an excerpt from the research notebook of Dr. Samantha Gregory, who was working at Johns Hopkins University on the D-11 compound in the summer of 2016. The notes were transcribed on a device known as a handheld voice recorder then fairly popular with academics at the time. The majority of the transcript has apparently been lost- this excerpt, which outlines an important breakthrough in the drug D-16, which was subsequently administered to inmates later in the year, is perhaps the most important section anyway, as far as history is concerned. -ed

By William “Doc” Stodden

[transcription picks up from previous pages, which are lost -ed] … feels that the compound belonging to lot 77–5645ebmd presents the highest probability of resolving the major issues of cell degeneration and immune system incompatibility. The lot, tested on mice in the lab has yielded significant and interesting results. After a period of 6 months, no discernible cell death or organ rejection was noted. Additionally, those mice administered the lot and exposed to a common virus showed immune systems not only uncompromised by the drug, but in fact more capable of fending off viruses than mice similarly exposed to various earlier D-11 lots. Increased immune system counts were also observed. Preliminary observations actually suggest a genetic recoding on the order that scientists have expected, without the negative effects we had been hoping to avoid. Shall begin limited clinical testing as soon as we obtain the permission from HSR, which we expect next week.

160506- Administered one course lot 77–5645ebmd and one placebo DB. No adverse reactions to lot noted in either subject. Will continue to observe.

160513- Observation continues. In seven days, Nurse Hansen will administer the T-cell test to both subjects, and observe for cells which are substantially altered.

160520- Blood test was administered this morning at 0700. Preliminary evidence suggests altered T-Cells and numbers in Patient #09565604, a Mr. John Hendrix. Patient #046753403 exhibits neither T-Cell alteration nor increase in numbers. We will have more conclusive results tomorrow…

Continue Reading on The New Haberdasher